title: A fully biodegradable patent ductus arteriosus occlude.
abstract: The purpose of this study was to develop a fully degradable occluder for the closure of PDA, which can be deployed percutaneously. The blends of biodegradable poly(ε-caprolactone) and poly(L-lactide-co-ε-caprolactone) with various compositions were studied as the potential material. The mechanical properties, i.e. elastic modulus and strain recovery, of the blends could be largely tailored by changing the continuous phase component. Moreover, the suitable blends were selected to fabricate a prototype and its in vitro biodegradation rate and blood compatibility, was evaluated. The current results indicate that no adverse effect on the platelet and leukocyte components of the blood. Biocompatibility implantation studies of the device showed acceptable tissue response. Finally, an artificial PDA conduit was created in a pig, and the device deployment was tested from a sheath: the device recovered within 2-3 min of unsheathing and fully sealed the conduit.
authors: School of Materials Science & Engineering, Nanyang Technological University, Singapore, 639798, Singapore, yingyinghuang@ntu.edu.sg.
authors: Ying Ying
authors: YY
authors: Huang
authors: Yee Shan
authors: YS
authors: Wong
authors: Jing Ni
authors: JN
authors: Chan
authors: Subbu S
authors: SS
authors: Venkatraman
mesh_terms: D020341:Absorbable Implants / Q000009:adverse effects; D000818:Animals; D001672:Biocompatible Materials / Q000009:adverse effects / Q000737:chemistry; D001696:Biomechanical Phenomena; D004374:Ductus Arteriosus, Patent / Q000601:surgery*; D005240:Feasibility Studies; D006801:Humans; D066298:In Vitro Techniques; D007958:Leukocyte Count; D008422:Materials Testing; D008855:Microscopy, Electron, Scanning; D023421:Models, Animal; D010976:Platelet Count; D011091:Polyesters / Q000737:chemistry; D011474:Prosthesis Design; D013552:Swine; D013556:Swine, Miniature; D060205:Therapeutic Occlusion / Q000009:adverse effects / Q000295:instrumentation; D013927:Thrombosis / Q000209:etiology; D013997:Time Factors; D054457:Tissue Scaffolds / Q000009:adverse effects / Q000737:chemistry
chemical_list: D001672:Biocompatible Materials; D011091:Polyesters; C016240:polycaprolactone; C062968:lactide-caprolactone copolymer
references: Catheter Cardiovasc Interv. 2011 Apr 1;77(5):664-70
references: 21433271
references: Catheter Cardiovasc Interv. 2001 Aug;53(4):571-6
references: 11515016
references: J Am Coll Cardiol. 1998 Mar 1;31(3):677-83
references: 9502653
references: Catheter Cardiovasc Interv. 2011 Jan 1;77(1):108-11
references: 20517997
references: Heart. 2000 May;83(5):570-3
references: 10768911
references: Heart Lung Circ. 2000 May;9(1):30-1
references: 16351990
references: J Vasc Interv Radiol. 1996 Nov-Dec;7(6):877-87
references: 8951756
references: Catheter Cardiovasc Interv. 2009 Sep 1;74(3):482-7
references: 19405162
references: J Am Coll Cardiol. 2004 Aug 4;44(3):513-9
references: 15358013
references: Catheter Cardiovasc Interv. 2010 Nov 1;76(5):696-702
references: 20690153
references: Am J Cardiol. 1992 Mar 15;69(8):815-6
references: 1546662
references: Catheter Cardiovasc Interv. 2010 Nov 1;76(5):687-95
references: 20815044
references: Catheter Cardiovasc Interv. 2010 Apr 1;75(5):778-81
references: 20091815
references: J Am Coll Cardiol. 2004 Jan 21;43(2):302-9
references: 14736453